Non-clear  	Non-clear  	 JJ	B-NP
cell  	cell  	 NN	I-NP
advanced  	advanced  	 VBD	I-NP
kidney  	kidney  	 NN	I-NP
cancer 	cancer 	 NN	I-NP
:  	:  	 :	O
is  	is  	 VBZ	O
there  	there  	 RB	O
a  	a  	 DT	O
gold  	gold  	 NN	O
standard 	standard 	 NN	O
?  	?  	 .	O
Renal  	Renal  	 JJ	B-NP
cell  	cell  	 NN	I-NP
carcinoma  	carcinoma  	 NNS	I-NP
( 	( 	 -LRB-	O
RCC 	RCC 	 NNP	B-NP
)  	)  	 -RRB-	O
accounts  	accounts  	 NNS	O
for  	for  	 IN	O
approximately  	approximately  	 RB	O
3 	3 	 CD	O
%  	%  	 NN	O
of  	of  	 IN	O
all  	all  	 DT	O
new  	new  	 JJ	O
cancer  	cancer  	 NN	B-NP
diagnosis  	diagnosis  	 VBD	I-NP
every  	every  	 DT	O
year 	year 	 NN	O
.  	.  	 .	O
RCC  	RCC  	 NNP	B-NP
arises  	arises  	 VBZ	O
from  	from  	 IN	O
the  	the  	 DT	O
renal  	renal  	 JJ	B-NP
epithelium  	epithelium  	 NN	I-NP
and  	and  	 CC	O
represents  	represents  	 VBZ	O
85 	85 	 CD	O
%  	%  	 NN	O
of  	of  	 IN	O
all  	all  	 DT	O
kidney  	kidney  	 NN	O
tumors 	tumors 	 NNS	O
.  	.  	 .	O
According  	According  	 VBG	O
to  	to  	 TO	O
histology 	histology 	 VB	O
,  	,  	 ,	O
these  	these  	 DT	O
neoplasms  	neoplasms  	 NNS	O
are  	are  	 VBP	O
divided  	divided  	 VBN	O
into  	into  	 IN	O
the  	the  	 DT	O
following  	following  	 JJ	O
types 	types 	 NNS	O
:  	:  	 :	O
clear  	clear  	 JJ	O
cell 	cell 	 NN	O
,  	,  	 ,	O
papillary 	papillary 	 NN	B-NP
,  	,  	 ,	O
chromophobe 	chromophobe 	 NN	B-NP
,  	,  	 ,	O
oncocytoma 	oncocytoma 	 NN	B-NP
,  	,  	 ,	O
collecting  	collecting  	 VBG	B-NP
duct 	duct 	 NN	I-NP
,  	,  	 ,	O
and  	and  	 CC	O
unclassified 	unclassified 	 JJ	O
.  	.  	 .	O
Approximately 	Approximately 	 RB	O
,  	,  	 ,	O
75 	75 	 CD	O
%  	%  	 NN	O
of  	of  	 IN	O
RCCs  	RCCs  	 NNS	B-NP
are  	are  	 VBP	O
of  	of  	 IN	O
the  	the  	 DT	O
clear  	clear  	 JJ	O
cell  	cell  	 NN	O
type  	type  	 NN	O
and  	and  	 CC	O
in  	in  	 IN	O
recent  	recent  	 JJ	O
years 	years 	 NNS	O
,  	,  	 ,	O
there  	there  	 EX	O
have  	have  	 VBP	O
been  	been  	 VBN	O
substantial  	substantial  	 JJ	O
advances  	advances  	 NNS	O
in  	in  	 IN	O
the  	the  	 DT	O
understanding  	understanding  	 NN	O
of  	of  	 IN	O
its  	its  	 PRP$	O
molecular  	molecular  	 JJ	B-NP
biology  	biology  	 NN	I-NP
leading  	leading  	 VBG	O
to  	to  	 TO	O
the  	the  	 DT	O
development  	development  	 NN	O
of  	of  	 IN	O
effective  	effective  	 JJ	O
treatments 	treatments 	 NNS	O
.  	.  	 .	O
However 	However 	 RB	O
,  	,  	 ,	O
there  	there  	 EX	O
is  	is  	 VBZ	O
still  	still  	 RB	O
an  	an  	 DT	O
area  	area  	 NN	O
of  	of  	 IN	O
uncertainty  	uncertainty  	 NN	O
with  	with  	 IN	O
regard  	regard  	 NN	O
to  	to  	 TO	O
non-clear  	non-clear  	 JJ	B-NP
cell  	cell  	 NN	I-NP
histologies 	histologies 	 NN	I-NP
.  	.  	 .	O
Scarce  	Scarce  	 JJ	B-NP
studies  	studies  	 NNS	I-NP
have  	have  	 VBP	O
been  	been  	 VBN	O
conducted  	conducted  	 VBN	O
testing  	testing  	 VBG	O
different  	different  	 JJ	O
drugs  	drugs  	 NNS	O
in  	in  	 IN	O
this  	this  	 DT	O
patient  	patient  	 JJ	O
population 	population 	 NN	O
.  	.  	 .	O
Thus 	Thus 	 RB	O
,  	,  	 ,	O
most  	most  	 JJS	O
of  	of  	 IN	O
the  	the  	 DT	O
evidence  	evidence  	 NN	O
comes  	comes  	 VBZ	O
from  	from  	 IN	O
small  	small  	 JJ	O
phase  	phase  	 NN	O
II  	II  	 NNP	O
trials 	trials 	 NNS	O
,  	,  	 ,	O
retrospective  	retrospective  	 JJ	B-NP
analysis 	analysis 	 NN	I-NP
,  	,  	 ,	O
or  	or  	 CC	O
expanded  	expanded  	 JJ	O
access  	access  	 NN	B-NP
programs 	programs 	 NNS	I-NP
.  	.  	 .	O
Recent  	Recent  	 JJ	B-NP
insights  	insights  	 NNS	I-NP
in  	in  	 IN	O
the  	the  	 DT	O
molecular  	molecular  	 JJ	B-NP
basis  	basis  	 NN	I-NP
of  	of  	 IN	O
these  	these  	 DT	O
tumors  	tumors  	 NNS	O
have  	have  	 VBP	O
opened  	opened  	 VBN	O
a  	a  	 DT	O
promising  	promising  	 JJ	O
research  	research  	 NN	B-NP
field 	field 	 NN	I-NP
.  	.  	 .	O
Molecules  	Molecules  	 NNS	O
targeting  	targeting  	 VBG	O
mammalian  	mammalian  	 JJ	B-NP
target  	target  	 NN	I-NP
of  	of  	 IN	I-NP
rapamycin 	rapamycin 	 NN	I-NP
,  	,  	 ,	O
epidermal  	epidermal  	 JJ	B-NP
growth  	growth  	 NN	I-NP
factor  	factor  	 NN	I-NP
receptor 	receptor 	 NN	I-NP
,  	,  	 ,	O
c-MET 	c-MET 	 NNP	O
,  	,  	 ,	O
vascular  	vascular  	 JJ	B-NP
endothelial  	endothelial  	 JJ	I-NP
growth  	growth  	 NN	I-NP
factor 	factor 	 NN	I-NP
,  	,  	 ,	O
and  	and  	 CC	O
platelet-derived  	platelet-derived  	 JJ	B-NP
growth  	growth  	 NN	I-NP
factor  	factor  	 NN	I-NP
are  	are  	 VBP	O
among  	among  	 IN	O
some  	some  	 DT	O
of  	of  	 IN	O
the  	the  	 DT	O
promising  	promising  	 JJ	O
drugs  	drugs  	 NNS	O
tested  	tested  	 VBN	O
in  	in  	 IN	O
this  	this  	 DT	O
setting 	setting 	 NN	O
.  	.  	 .	O
This  	This  	 DT	O
article  	article  	 NN	O
reviews  	reviews  	 VBZ	O
the  	the  	 DT	O
mechanisms  	mechanisms  	 NNS	O
of  	of  	 IN	O
disease  	disease  	 NN	O
on  	on  	 IN	O
RCC  	RCC  	 NNP	B-NP
and  	and  	 CC	O
summarizes  	summarizes  	 JJ	O
treatment  	treatment  	 NN	B-NP
options  	options  	 NNS	I-NP
with  	with  	 IN	O
a  	a  	 DT	O
particular  	particular  	 JJ	O
focus  	focus  	 NN	O
on  	on  	 IN	O
patients  	patients  	 NNS	O
with  	with  	 IN	O
non-clear  	non-clear  	 JJ	B-NP
cell  	cell  	 NN	I-NP
tumors 	tumors 	 NNS	I-NP
.  	.  	 .	O
